Live Breaking News & Updates on Brad Canino|Page 4

Stay updated with breaking news from Brad canino. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Blueprint Medicines Corp (BPMC) Q3 2021 Earnings Call Transcript

BPMC earnings call for the period ending September 30, 2021. ....

United States , Raymond James , Goldman Sachs , Arlinda Lee , Benjamin Kallo , David Nierengarten , Christy Rossi , Jones Morgan Stanley , Peter Lawson , Andrew Berens , Salveen Richter , Becker Hewes , Marc Frahm , Kristin Hodous , Paul Jeng Guggenheim , David Nierengarten Wedbush , Fouad Namouni , Dane Leone Raymond James , Jeff Albers , Reni Benjamin , Dane Leone , Joel Beatty , Kate Haviland , Mike Landsittel , Michael Schmidt , Peter Lawson Barclays ,

3 Biotech Stocks That Could Double Soon

3 Biotech Stocks That Could Double Soon
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Patrick Trucchio , Brad Canino , Credit Suisse , பிராட் கேனினோ , கடன் ஸ்யூயி ,

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript

Seattle Genetics (SGEN) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
Seattle Genetics (NASDAQ: SGEN)
Good day and welcome to Seagen first-quarter 2021 financial results conference call. [Operator instructions] After today s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I would now like to turn the conference over to Peggy Pinkston, senior vice president of investor relations.
Please go ahead.
Senior Vice President of Investor Relations
Thank you, operator, and good afternoon, everyone. I d like to welcome all of you to Seagen s first-quarter 2021 financial results conference call. This afternoon, we issued a press release with our results. The press release and supporting slides are available on our website in the investor section, events and presentations page. ....

United Kingdom , United States , Great Britain , Cory Kasimov , Andy Hsieh , Peggy Pinkston , Sheldon Chuan Barclays , Stephen Willey , Tisotumab Vedotin , Gena Wang , Salveen Richter Goldman Sachs , Connor Meehan Morgan Stanley , Kennen Mackay , Andrew Berens , Padcev Europe , Salveen Richter , Geoff Meacham , Jay Olson , America Merrill Lynch , Greg Harrison , Clay Siegall , Zhiqiang Shu , Ladiratuzumab Vedotin , Michael Schmidt Guggenheim , Reni Benjamin , Roger Dansey ,

MacroGenics (MGNX) Q1 2021 Earnings Call Transcript

MacroGenics (MGNX) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
MacroGenics (NASDAQ: MGNX)
Good afternoon, we will begin the MacroGenics 2021 first-quarter corporate progress and financial results conference call in just a moment. All participants are in listen-only mode at the moment, and we will conduct a question-and-answer session at the conclusion of the call. At this point, I will turn the call over to Jim Karrels, senior vice president, chief financial officer of MacroGenics.
Jim Karrels
Senior Vice President, Chief Financial Officer, and Treasurer
Thank you, operator. Good afternoon and welcome to MacroGenics ss conference call to discuss our first-quarter 2021 financial and operational results. For anyone who has not had the chance to review these results, we issued a press release this afternoon, outlining today s announcements, which is availa ....

Hong Kong , Jonathan Miller Evercore , Etzer Darout Cowen , Stephen Willey , David Lebowitz , Jonathan Miller , Etzer Darout , Jim Karrels , Jonathan Chang , David Lebowitz Morgan Stanley , Peter Lawson , Scott Koenig , Yigal Nochomovitz , Peter Lawson Barclays , Yigal Nochomovitz Citi , Brad Canino , Morgan Stanley , Zai Lab , Credit Suisse , Stephen Willey Stifel Financial Corp , Greater China Zai Lab , Company Analyst , Motley Fool Macrogenics , Call Transcript , Motley Fool Logo , Vice President ,